Cornelia Hain

Cornelia Hain currently serves as the Head of Device Development at Polpharma Biologics since May 2023, previously holding the position of Program Head Device Development at Novartis from November 2019 to May 2023, and serving as a Senior Expert in Engineering with a focus on Human Factors and Usability. Throughout a distinguished career at Novartis, Cornelia Hain also worked as a Medical Device Manager II and a Senior Manager in Regulatory Affairs - Labeling within the Sandoz Division, contributing significantly to regulatory labeling and project management for biosimilars and medical devices. Prior to this, experience includes leadership roles in regulatory labeling and artwork at CROMA-PHARMA and editing work at the Linguistics Department of the University of Vienna. Cornelia Hain holds a Mag.phil in Germanic Languages, Literatures, and Linguistics from Vienna University and has furthered education at University College London.